Related Experiment Video
Updated: Feb 13, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
B49, a BST-2-based peptide, inhibits adhesion and growth of breast cancer cells
Wadie D Mahauad-Fernandez1,2, Chioma M Okeoma3,4
1Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, 51 Newton Road, Iowa City, IA, 52242-1109, USA.
Abstract:
Bone marrow stromal antigen 2 (BST-2) also known as Tetherin has been implicated in the growth and progression of many cancers. BST-2 employs its pro-tumor effects through the formation of BST-2:BST-2 dimers which ultimately promotes cell to cell and cell to matrix adhesion, cell motility, survival, and growth. The aim of this study was to evaluate the effect of a novel BST-2-based peptide-B49 on adhesion and growth of breast cancer cells. Homotypic/heterotypic adhesion, three-dimensional spheroid formation, and anchorage-independent growth were used to assess the effect of B49 on cell adhesion and growth. Additionally, we provide evidence of the anti-tumor effect of B49 in a preclinical mouse model of breast cancer. Results show that breast cancer cell adhesion to other cancer cells or components of the tumor microenvironment were inhibited by B49. Most well-known evaluation indexes of cancer cell growth, including spheroid formation, anchorage-independent, and primary tumor growth were significantly inhibited by B49. These data affirm that i) BST-2 plays a key role in mediating breast cancer cell adhesion and growth, and ii) B49 and its analog B49Mod1 significantly inhibits BST-2-mediated cancer cell adhesion and growth. Therefore, B49 and its analogs offer a promising anti-adhesion and therapeutic lead for BST-2-dependent cancers.
Insights
A novel peptide, B49, effectively inhibits breast cancer cell adhesion and growth by targeting Bone marrow stromal antigen 2 (BST-2). This peptide shows promise as a therapeutic lead for BST-2-dependent cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Bone marrow stromal antigen 2 (BST-2), also known as Tetherin, is implicated in cancer growth and progression.
- BST-2 promotes tumor effects via dimer formation, enhancing cell adhesion, motility, survival, and growth.
Purpose of the Study:
- To evaluate the effect of a novel BST-2-based peptide, B49, on breast cancer cell adhesion and growth.
- To assess B49's anti-tumor efficacy in a preclinical breast cancer model.
Main Methods:
- Assessed homotypic/heterotypic adhesion, 3D spheroid formation, and anchorage-independent growth to evaluate B49's impact on cell adhesion and growth.
- Utilized a preclinical mouse model to provide evidence of B49's anti-tumor effect.
Main Results:
- B49 significantly inhibited breast cancer cell adhesion to other cancer cells and tumor microenvironment components.
- B49 demonstrated significant inhibition of key cancer cell growth indicators: spheroid formation, anchorage-independent growth, and primary tumor growth.
Conclusions:
- BST-2 plays a crucial role in mediating breast cancer cell adhesion and growth.
- B49 and its analog B49Mod1 effectively inhibit BST-2-mediated cancer cell adhesion and growth.
- B49 and its analogs represent a promising therapeutic strategy for BST-2-dependent cancers.
Related Concept Videos
Peptide Bonds
Adhesion
Capillary action is a result of water’s adhesive tendencies. When a narrow...
Cell Adhesion in Plants
Pectins are complex heteropolymers mainly composed of negatively-charged α-D-glucopyranosyl uronic acid and some neutral glycosyl residues such as α-L-rhamnopyranose, α-L-arabinofuranose,...
Feedback Inhibition
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...

